Fumoy,
It has been a long time between drinks for many small cap stem cell companies - but like the tide these things change. Cynata has brilliant timing in this regard.
There will be a lot of people and brokers running there ruler over cyp thinking what added value could this company have to an existing stem cell company and for that matter specific treatment.
$2-4 target for cynata, page-5
-
- There are more pages in this discussion • 386 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $41.58M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 22.5¢ | $24.97K | 107.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 179 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 21993 | 2 |
View Market Depth
| Last trade - 15.32pm 18/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |